Yuqing Song1, Xia Xie2,3, Yanling Chen4, Ying Wang4, Hui Yang5, Anliu Nie6, Hong Chen7. 1. West China School of Nursing/West China Hospital, Sichuan University, No. 37, Guoxuexiang, Wuhou District, Chengdu, 610041, Sichuan, China. 2. Department of Nursing, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China. 3. School of Nursing, North Sichuan Medical College, Nanchong, 637000, Sichuan, China. 4. Department of Rheumatology and Immunology, West China Hospital, Sichuan University, No. 37, Guoxuexiang, Wuhou District, Chengdu, 610041, Sichuan, China. 5. Nursing Department, The First Affiliated Hospital of Harbin Medical University, No.23 Youzheng Street, Nangang, Harbin, 150001, Heilongjiang, China. 6. Emergency Department, The First Affiliated Hospital of Guangzhou Medical University, No. 151 Yanjiangxi Road, Guangzhou, Guangdong, China. 7. West China School of Nursing/West China Hospital, Sichuan University, No. 37, Guoxuexiang, Wuhou District, Chengdu, 610041, Sichuan, China. 1366109878@qq.com.
Abstract
BACKGROUND: Ankylosing spondylitis (AS), as a common inflammatory rheumatic disease, often causes depression and impaired health-related quality of life (QoL). Although positive effects of patient education have been demonstrated, limited studies explored the benefits of education via mobile applications for AS patients. This study aimed to evaluate the effects of the WeChat-based educational intervention on depression, health-related QoL, and other clinical outcomes in AS patients. METHODS: We conducted a single-blind randomized controlled trial from March to December 2017. Patients were recruited and randomized into the intervention group which received a 12-week WeChat-based educational intervention (consisting of four individual online educational sessions, online educational materials) or the control group receiving standard care. Data was collected at baseline and 12 weeks. Outcomes were measured by Beck Depression Inventory-II, the Medical Outcomes Study Short Form 36-item Health Survey (SF-36), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Patient Global Score (BAS-G), and visual analog scales. RESULTS: A total of 118 patients with AS were included and analyzed. Measures at baseline were comparable between groups. After the intervention, the intervention group reported significant higher scores of all domains of SF-36 except for physical functioning and validity, compared with the control group. Additionally, patients in the intervention group had lower depressive symptoms than the control group. No significant difference in other outcomes was observed at 12 weeks. CONCLUSIONS: This study found that the 12-week educational intervention via WeChat had positive effects on reducing depressive symptoms and improving health-related QoL in Chinese patients with AS. We suggest that this intervention can be integrated into current routine care of AS patients. TRIAL REGISTRATION: This study has been approved by the hospital's ethics committee (ID: 20160364) in 2016 and registered at the Chinese Clinical Trail Registry (registry number: ChiCTR-IPR-16009293 ).
RCT Entities:
BACKGROUND:Ankylosing spondylitis (AS), as a common inflammatory rheumatic disease, often causes depression and impaired health-related quality of life (QoL). Although positive effects of patient education have been demonstrated, limited studies explored the benefits of education via mobile applications for ASpatients. This study aimed to evaluate the effects of the WeChat-based educational intervention on depression, health-related QoL, and other clinical outcomes in ASpatients. METHODS: We conducted a single-blind randomized controlled trial from March to December 2017. Patients were recruited and randomized into the intervention group which received a 12-week WeChat-based educational intervention (consisting of four individual online educational sessions, online educational materials) or the control group receiving standard care. Data was collected at baseline and 12 weeks. Outcomes were measured by Beck Depression Inventory-II, the Medical Outcomes Study Short Form 36-item Health Survey (SF-36), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing SpondylitisPatient Global Score (BAS-G), and visual analog scales. RESULTS: A total of 118 patients with AS were included and analyzed. Measures at baseline were comparable between groups. After the intervention, the intervention group reported significant higher scores of all domains of SF-36 except for physical functioning and validity, compared with the control group. Additionally, patients in the intervention group had lower depressive symptoms than the control group. No significant difference in other outcomes was observed at 12 weeks. CONCLUSIONS: This study found that the 12-week educational intervention via WeChat had positive effects on reducing depressive symptoms and improving health-related QoL in Chinese patients with AS. We suggest that this intervention can be integrated into current routine care of ASpatients. TRIAL REGISTRATION: This study has been approved by the hospital's ethics committee (ID: 20160364) in 2016 and registered at the Chinese Clinical Trail Registry (registry number: ChiCTR-IPR-16009293 ).
Authors: Désirée van der Heijde; Sofia Ramiro; Robert Landewé; Xenofon Baraliakos; Filip Van den Bosch; Alexandre Sepriano; Andrea Regel; Adrian Ciurea; Hanne Dagfinrud; Maxime Dougados; Floris van Gaalen; Pál Géher; Irene van der Horst-Bruinsma; Robert D Inman; Merryn Jongkees; Uta Kiltz; Tore K Kvien; Pedro M Machado; Helena Marzo-Ortega; Anna Molto; Victoria Navarro-Compàn; Salih Ozgocmen; Fernando M Pimentel-Santos; John Reveille; Martin Rudwaleit; Jochen Sieper; Percival Sampaio-Barros; Dieter Wiek; Jürgen Braun Journal: Ann Rheum Dis Date: 2017-01-13 Impact factor: 19.103
Authors: Heidi A Zangi; Mwidimi Ndosi; Jo Adams; Lena Andersen; Christina Bode; Carina Boström; Yvonne van Eijk-Hustings; Laure Gossec; Jana Korandová; Gabriel Mendes; Karin Niedermann; Jette Primdahl; Michaela Stoffer; Marieke Voshaar; Astrid van Tubergen Journal: Ann Rheum Dis Date: 2015-03-03 Impact factor: 19.103
Authors: Konstantinos Kotsis; Paraskevi V Voulgari; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2014-09-05 Impact factor: 2.217
Authors: Sizheng Zhao; Daniel Thong; Natasha Miller; Stephen J Duffield; David M Hughes; Laura Chadwick; Nicola J Goodson Journal: Arthritis Res Ther Date: 2018-07-11 Impact factor: 5.156
Authors: Annette de Thurah; Andrea Marques; Savia de Souza; Cynthia S Crowson; Elena Myasoedova Journal: Ther Adv Musculoskelet Dis Date: 2022-03-17 Impact factor: 5.346